Virtual Library
Start Your Search
Jamie L Studts
Author of
-
+
MA17 - New Methods to Improve Lung Cancer Patients Outcomes (ID 918)
- Event: WCLC 2018
- Type: Mini Oral Abstract Session
- Track: Nursing and Allied Professionals
- Presentations: 1
- Moderators:
- Coordinates: 9/25/2018, 13:30 - 15:00, Room 205 AC
-
+
MA17.02 - Early Accrual to a Precision Lung Cancer Survivorship Intervention: The Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (ID 14179)
13:35 - 13:40 | Presenting Author(s): Jamie L Studts
- Abstract
- Presentation
Background
Recent advances in early detection and treatment of lung cancer have created a need for survivorship care interventions to reduce the psychosocial and symptom burden of lung cancer, but few interventions address the unique experience of lung cancer survivors and their caregivers. Leveraging shared decision making and motivational interviewing, the Kentucky LEADS Collaborative developed a precision psychosocial intervention addressing the unique experiences and challenges of individuals diagnosed with lung cancer and their caregivers. This sub-study describes the demographic, diagnostic, and psychosocial characteristics of the initial participants in the Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program.
a9ded1e5ce5d75814730bb4caaf49419 Method
Participants include 61 lung cancer survivors across 9 lung cancer care sites in Kentucky, USA. Data were drawn from baseline surveys of demographic characteristics, disease/treatment information, symptom burden, psychosocial functioning and quality of life administered to lung cancer survivors and caregivers enrolled in the single-arm intervention trial.
4c3880bb027f159e801041b1021e88e8 Result
Of the first 61 LC survivors enrolled, 32 had a caregiver join them as participants in the intervention (53%). Participants had a mean age of 62 years. Approximately 20% of LC survivors did not have a caregiver available to participate, and 27% declined to invite a caregiver join the program. Most participating caregivers were spouses (63%), but siblings (10%) and children (19%) were also included. Most survivors were female (66%), Caucasian (97%), and covered by health insurance (95%), and 59% were married or living in a committed relationship. Most participants had been diagnosed with non-small cell lung cancer (84%) and late-stage disease (IIIB-IV; 53%). Most participants had a history of smoking (95%); 30% had smoked within the past 30 days, and 29% were current smokers. Among current smokers, participants reported very high levels of quit planning (9.23±2.77) and quitting confidence (9.14±2.89). Finally, approximately 55% reported clinically significant distress, with a mean level of distress of 3.98 (2.99) on a scale from 0-10.
8eea62084ca7e541d918e823422bd82e Conclusion
Early accrual to the trial has exceeded expectations. Most survivors had advanced disease and reported significant distress. A substantial minority continued to use tobacco. Data suggest that modifications made to the survivorship approach emphasizing empathy and patient preference may help improve intervention acceptability and feasibility. Subsequent analyses will evaluate the impact of the intervention on quality of life, psychosocial functioning, and symptom burden. Data will also be collected regarding acceptability of the intervention and potential program changes to optimize benefits.
6f8b794f3246b0c1e1780bb4d4d5dc53Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
-
+
MS11 - Stigma and Lung Cancer: Unintended Translational Consequences of Effective Tobacco Control (ID 790)
- Event: WCLC 2018
- Type: Mini Symposium
- Track: Prevention and Tobacco Control
- Presentations: 1
- Moderators:
- Coordinates: 9/24/2018, 15:15 - 16:45, Room 206 AC
-
+
MS11.03 - Prevalence of Perceived Lung Cancer Stigma Among Medical and Nursing Students (ID 11447)
15:55 - 16:15 | Presenting Author(s): Jamie L Studts
- Abstract
- Presentation
Abstract not provided
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
-
+
P2.11 - Screening and Early Detection (Not CME Accredited Session) (ID 960)
- Event: WCLC 2018
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 1
- Moderators:
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.11-26 - First of its Kind Multi-Pronged Training for PCPs in an Epicenter of Lung Cancer – What Was Achieved in Two Years? (ID 14156)
16:45 - 18:00 | Author(s): Jamie L Studts
- Abstract
Background
Kentucky’s lung cancer (LC) rates have been the highest in the U.S. and amongst the highest in the world. Primary care provider (PCP) understanding and adoption of the U.S. Preventive Services Task Force (USPSTF) recommendation for LCS with low-dose CT (LDCT) were very low over a year after its release. LDCT is the only recommended tool for early detection of LC; making PCP education crucial for impacting the leading cause of cancer death.
a9ded1e5ce5d75814730bb4caaf49419 Method
The Kentucky LEADS (Lung cancer Education Awareness Detection and Survivorship) Collaborative was initiated to reduce the LC burden through novel interventions to promote provider education (PE), survivorship care, and prevention/early detection. The PE component sought to improve referral of high-risk patients to LCS incorporating quality shared decision-making and tobacco cessation counseling through multi-pronged continuing education (CE) programs for PCPs statewide. Four unique interventions were developed, implemented, and evaluated: an interactive online course, didactic presentations with audience response system, academic detailing with a LEADS Primary Care Toolkit, and a webinar.
4c3880bb027f159e801041b1021e88e8 Result
Participation in these CE programs was unprecedented including 1,400+ PCPs (more than 20% of the state’s total) and 2,700+ health professionals total. Participation based on platform type, provider discipline, specialty, and years in practice will be shared, as well as self-reported changes in practice behaviors as a result of the training(s) and feedback on which elements were of most value. A remarkable increase in LDCT scans in accredited facilities statewide for eligible patients after the intervention period will be discussed, as well as potential for lower numbers needed to screen for the early detection of LC in higher risk geographic areas, as compared to those for the National Lung Screening Trial (NLST), upon which the USPSTF recommendation was based.
8eea62084ca7e541d918e823422bd82e Conclusion
Appropriate utilization of LCS must be an urgent and pervasive priority among referring providers. Limitations for screening such as LDCT availability, patient awareness and acceptance, and negative perceptions of treatment options are being diminished. However, PCP requirements for appropriate referral must be addressed for optimal utilization of this screening tool. These include provider understanding of recommendations, eligibility, and screening risks, benefits, and limitations, as well as knowledge of available screening facilities, reimbursement for shared decision making, screening coverage, and available resources. Adoption of new screening modalities by providers and patients alike always takes time, but education for referring providers is the “next big thing” in improving LC outcomes. It is imperative that it be comprehensive, appealing, innovative, and evidence-based.
6f8b794f3246b0c1e1780bb4d4d5dc53
